RxDoctor Payments Data

John Aziz, MD

Psychiatry · Logan, OHNPI 1679592075

Payments from drug & device makers

$1,465in general payments, 2019–2025

Across 57 payments — averaging $25.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$531
  • AbbVie$294
  • Janssen Scientific Affairs, LLC$200
  • Lundbeck LLC$156
  • Bausch Health US, LLC$92
  • Otsuka America Pharmaceutical, Inc.$81
  • plus $111 from 4 others

What the payments were for

  • Consulting fees$20014%
  • Food & beverage$1,26586%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,465 in reported general payments places this provider in the 75th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$23,718
Medicare patients
37
Services billed
309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl28$142,578
Lurasidone Hcl16$4,190
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl30$3,041
Bupropion XlBupropion Hcl81$1,167
Duloxetine Hcl45$670
Venlafaxine Hcl ErVenlafaxine Hcl48$646
Risperidone59$581
Escitalopram Oxalate45$424
Trazodone Hcl63$408
Quetiapine Fumarate58$380
Memantine Hcl21$360
Buspirone Hcl17$292
Lamotrigine50$277
Aripiprazole14$239
Mirtazapine17$197

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$531$142,57828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Logan

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →